This briefing reflects reporting and polling available as of Aug. 29, 2026. Candidates, endorsements and polling can change before Election Day on Nov. 3, 2026.
Why This Race Matters
Iowa’s 1st District will see the same two candidates face off for a third consecutive election, in a seat that has been decided by a few hundred votes or fewer in two of the last three cycles. Beyond the personal rematch, the race is shaping up as a national test case for how voters weigh a health-focused Democratic challenge against tariffs and healthcare votes that a sitting Republican has taken as part of her party’s congressional majority.
The Race
Rep. Mariannette Miller-Meeks, an ophthalmologist and Army veteran, first won the seat in 2020 by six votes under the district’s previous lines, running against a different Democratic opponent. Since then, redistricting created the current 1st District, covering 20 counties in southeast Iowa including Iowa City, Davenport, Muscatine and Burlington, a district Trump carried by roughly 54% in 2024. Democrat Christina Bohannan, a University of Iowa law professor and former state legislator, has run against Miller-Meeks in both prior elections under the new lines, losing by a wider margin in 2022 and by just 799 votes, or 0.2%, after a recount in 2024.
Both candidates won June primaries comfortably: Miller-Meeks defeated a self-described “MAGA” primary challenger, and Bohannan defeated a first-time candidate campaigning on universal healthcare. Cook Political Report and Sabato’s Crystal Ball both rate the race a toss-up. Miller-Meeks has maintained a fundraising edge, reporting more than $2 million cash on hand after the second quarter of 2026.
The Candidates
Mariannette Miller-Meeks (R) served more than two decades in the Army as a nurse and later a physician before working as an ophthalmologist. She lives in Ottumwa, outside the district’s boundaries. According to CQ’s vote-tracking data, she voted with her party about 91% of the time in her first year in Congress, rising to roughly 96% by her third term. Her National Taxpayers Union fiscal rating fell from 65% in 2023 to 52% in 2024, below the average for House Republicans. She has also led bipartisan legislation with Democratic Reps. Doris Matsui and Jake Auchincloss aimed at expanding Medicare beneficiaries’ access to lower-cost prescription drugs.
Christina Bohannan teaches law at the University of Iowa and previously served in the Iowa House. This is her third consecutive congressional campaign, and she has built one of the stronger Democratic fundraising and volunteer networks in the state as a result. Her campaign centers on reversing Medicaid cuts, raising Medicaid income thresholds, and tying Miller-Meeks’s voting record to higher healthcare and consumer costs.
Top Issues
Healthcare and Medicaid. Miller-Meeks voted for the 2025 tax and spending law’s Medicaid changes and against extending expiring Affordable Care Act marketplace subsidies, defending both votes as targeting “fraud” rather than eligible beneficiaries. Bohannan has made reversing those changes central to her campaign, citing a rural hospital in the district she says is at renewed financial risk. A KFF estimate cited in Iowa reporting projects roughly 110,000 more Iowans could become uninsured by 2034 from the combined effect of Medicaid changes and subsidy expiration, a projection rather than a current, already-realized figure.
Tariffs. The Supreme Court ruled on Feb. 20, 2026, that the International Emergency Economic Powers Act does not authorize the president to impose tariffs, striking down a central pillar of the administration’s trade policy in a 6-3 decision. Trump moved the same day to reimpose a 10% tariff under a different statute, Section 122 of the Trade Act, meaning the ruling did not end tariff costs for consumers even though it curtailed the broader IEEPA authority Democrats have criticized Miller-Meeks for not opposing.
Rural healthcare funding. Republicans, including Miller-Meeks, point to the law’s Rural Health Transformation Program, which is set to distribute $50 billion nationally through 2030, as an offset to Medicaid reductions; Iowa’s program received $209 million in initial funding. Democrats argue the offset does not match the scale of the cuts.
Evidence Check
Claim (Miller-Meeks): ACA marketplace subsidies go to profitable insurance companies, are affected by fraud, and “have ZERO income caps.” Check: the income-cap description accurately reflects the structure of the pandemic-era expanded subsidies, which removed a prior income ceiling for eligibility. The fraud characterization is a more disputed claim this article could not verify against independent audit data, and enrollment figures cited in Iowa reporting show a drop in ACA marketplace sign-ups this year, which is consistent with subsidies lapsing but does not by itself establish the fraud claim.
Claim (Bohannan and allied groups): Miller-Meeks’s tariff and healthcare votes have raised costs for ordinary Iowans. Check: a Tax Foundation analysis cited in Iowa reporting estimated tariffs functioned as roughly a $1,000 tax increase per average American household in 2025. That figure is a national estimate, not an Iowa-specific one, and this article could not independently verify a district-level cost figure.
Supporter Voices
Shaughnessy Naughton, president of the 314 Action Fund, a PAC that backs candidates with science and medical backgrounds, said her group is investing heavily in the race because of what she called the clearest path for Democrats to flip a competitive seat this cycle; the group spent $750,000 on ads against Miller-Meeks over Medicaid. This briefing could not locate comparably sourced supporter quotes on Miller-Meeks’s side or from undecided district voters.
How This Race Is Being Framed
Miller-Meeks has branded herself “the doctor in the House” fighting insurance companies on constituents’ behalf, a framing Democratic-aligned outlets have called misleading given her voting record on subsidies and Medicaid. Bohannan has framed the race as a referendum on whether Miller-Meeks’s votes have made healthcare and everyday costs worse for the district, rather than a broader ideological contest. The race’s history of razor-thin margins means both sides are treating turnout mechanics, not persuasion alone, as decisive.
Related Links
- Iowa 1st District: Bohannan, Miller-Meeks to face off in November, AP projects – Iowa Capital Dispatch
- Health care shaping up as central issue in IA-01 campaign – Bleeding Heartland
- Rep. Mariannette Miller-Meeks cast votes to gut healthcare and support tariffs – The Iowa Independent
- Democrats attack GOP doctor for cuts to Medicaid in tight Iowa House race – Washington Examiner
- Conservative group launches ad campaign highlighting Rep. Miller-Meeks, Nunn work on tax cuts – Iowa Capital Dispatch
- Supreme Court Strikes Down IEEPA Tariffs: What Importers Need to Know Now – Holland & Knight
Discussion Questions
- What do you make of a district that has faced the same two candidates three elections in a row?
- Do you find Miller-Meeks’s fraud-focused defense or Bohannan’s cost-focused attack more convincing?
- How should voters weigh a projection, like the 110,000-uninsured estimate here, against a claim about current effects?
- Does the Supreme Court’s tariff ruling change how you think about candidates’ records on trade policy?
- What responsibility does an incumbent have when independent fiscal ratings of their record decline over time?
- How much should a representative’s home address relative to district lines matter to you?
- Why do you think this seat keeps coming down to such small margins, cycle after cycle?
- What would it take to convince you a “fraud” claim about a program is accurate versus exaggerated?
- How should national money, like the $750,000 in PAC spending here, factor into how you view a local race?
- Imagine you are an Iowa voter who has voted for both candidates in past cycles. What would decide your vote this year?
